MedTech — Other (income) expense, net
Business Segments · Other (income) expense, netJohnson & Johnson MedTech — Other (income) expense, net decreased by 98.9% to $2.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 118.2%, from -$11.00M to $2.00M. Over 2 years (FY 2022 to FY 2024), MedTech — Other (income) expense, net shows a downward trend with a -31.8% CAGR.
Analysis
StatementSegment
CategoryProfitability
SignalContext dependent
VolatilityVolatile
First reportedQ1 2022
Last reportedQ3 2025
How to read this metric
Large, unexpected values may indicate one-time events or non-recurring financial impacts.
Detailed definition
Includes non-operating income or expenses specific to the MedTech segment, such as gains or losses from asset sales, lit...
Peer comparison
Standard 'Other' line item found in segment reporting across most industries.
Metric ID:
jnj_segment_medtech_other_income_expense_netHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $138.25M | $138.25M | $138.25M | $138.25M | -$147.25M | -$147.25M | -$147.25M | -$147.25M | -$47.00M | $231.00M | -$11.00M | $84.00M | -$60.00M | $190.00M | $2.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -206.5% | +0.0% | +0.0% | +0.0% | +68.1% | +591.5% | -104.8% | +863.6% | -171.4% | +416.7% | -98.9% |
| YoY Change | — | — | — | — | -206.5% | -206.5% | -206.5% | -206.5% | +68.1% | +256.9% | +92.5% | +157.0% | -27.7% | -17.7% | +118.2% |
Range-$147.25M – $231.00M
CAGR-70.2%
Avg YoY Growth-16.2%
Median YoY Growth-17.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — other (income) expense, net?
- Johnson & Johnson (JNJ) reported medtech — other (income) expense, net of $2.00M in Q3 2025.
- How has Johnson & Johnson's medtech — other (income) expense, net changed year-over-year?
- Johnson & Johnson's medtech — other (income) expense, net increased by 118.2% year-over-year, from -$11.00M to $2.00M.
- What is the long-term trend for Johnson & Johnson's medtech — other (income) expense, net?
- Over 2 years (2022 to 2024), Johnson & Johnson's medtech — other (income) expense, net has grown at a -31.8% compound annual growth rate (CAGR), from $553.00M to $257.00M.
- What does medtech — other (income) expense, net mean?
- Miscellaneous income or expenses not related to the core business operations of the MedTech segment.